Clinical Trial Update: A Study Evaluating the Efficacy and Safety of ALG-000184 Compared With Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg- Negative Adult Subjects With Chronic Hepatitis B (B-SUPREME) [Phase 2]

View source ↗

Summary

Phase 2 trial update describing a study that compares ALG-000184 with tenofovir disoproxil fumarate in untreated adults with chronic hepatitis B, including both…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• ALG-000184
• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)

Snippet

Sponsor: Aligos Therapeutics | Conditions: Chronic Hepatitis B Infection | Phase 2 | Status: RECRUITING